世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000040398

T細胞リンパ腫の世界市場(2024-2028)

TechNavio

Global T-cell Lymphoma Market 2024-2028

発刊日 2024/08/01

言語英語

体裁PDF/135ページ

ライセンス/価格135ページ

0000040398

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

T細胞リンパ腫市場は、2023年から2028年の間に8億180万米ドル成長すると予測されており、予測期間中にCAGRは8.51%で加速すると予測されています。このレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題、および約25のベンダーをカバーするベンダー分析を提供します。

このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。市場は、高齢者人口の増加、再発または難治性のT細胞リンパ腫患者に対する治療薬の承認の増加、T細胞リンパ腫の発生率の増加によって牽引されています。

調査範囲

  • 市場セグメント
    ➣ タイプ別
      ◇ 末梢性T細胞リンパ腫
      ◇ T細胞リンパ芽球性リンパ腫
    ➣ 地域別
      ◇ 北アメリカ
      ◇ ヨーロッパ
      ◇ アジア
      ◇ その他の地域

この調査は、技術の進歩が今後数年間のT細胞リンパ腫市場の成長を促進する主な理由の1つであることを特定しています。また、患者サポート プログラムと戦略的提携の増加により、市場での大きな需要がもたらされるでしょう。

T細胞リンパ腫市場に関するレポートは、次の分野をカバーしています。

  • T細胞リンパ腫市場の規模
  • T細胞リンパ腫市場の予測
  • T細胞リンパ腫市場の業界分析

堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されています。

  • 調査企業
    ➣ AbbVie Inc.
    ➣ Accredo Health Group Inc.
    ➣ AstraZeneca PLC
    ➣ Autolus Therapeutics PLC
    ➣ Baxter International Inc.
    ➣ Biogen Inc.
    ➣ Bristol Myers Squibb Co.
    ➣ Eli Lilly and Co.
    ➣ F. Hoffmann La Roche Ltd.
    ➣ Genmab A
    ➣ GlaxoSmithKline PLC
    ➣ H. Lee Moffitt Cancer Center and Research Institute Inc.
    ➣ Johnson and Johnson Services Inc.
    ➣ Macopharma SA
    ➣ Merck and Co. Inc.
    ➣ Mundipharma International Ltd.
    ➣ Novartis AG
    ➣ Pfizer Inc.
    ➣ Sanofi SA
    ➣ Syros Pharmaceuticals, Inc
    ➣ Teva Pharmaceutical Industries Ltd.

また、本レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。

このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。

レポート詳細

目次

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning

2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis

3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size
4.1 Global T-Cell Lymphoma Market 2018 - 2022
Historic Market Size - Data Table on Global T-Cell Lymphoma Market 2018 - 2022 ($ million)
4.2 Type segment analysis 2018 - 2022
Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.3 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.4 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type
6.1 Market segments
Chart on Type - Market share 2023-2028 (%)
Data Table on Type - Market share 2023-2028 (%)
6.2 Comparison by Type
Chart on Comparison by Type
Data Table on Comparison by Type
6.3 Peripheral T-cell lymphomas - Market size and forecast 2023-2028
Chart on Peripheral T-cell lymphomas - Market size and forecast 2023-2028 ($ million)
Data Table on Peripheral T-cell lymphomas - Market size and forecast 2023-2028 ($ million)
Chart on Peripheral T-cell lymphomas - Year-over-year growth 2023-2028 (%)
Data Table on Peripheral T-cell lymphomas - Year-over-year growth 2023-2028 (%)
6.4 T-cell lymphoblastic lymphoma - Market size and forecast 2023-2028
Chart on T-cell lymphoblastic lymphoma - Market size and forecast 2023-2028 ($ million)
Data Table on T-cell lymphoblastic lymphoma - Market size and forecast 2023-2028 ($ million)
Chart on T-cell lymphoblastic lymphoma - Year-over-year growth 2023-2028 (%)
Data Table on T-cell lymphoblastic lymphoma - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Type
Market opportunity by Type ($ million)
Data Table on Market opportunity by Type ($ million)

7 Customer Landscape
7.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

8 Geographic Landscape
8.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
8.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
8.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
8.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
8.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
8.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
8.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
8.8 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
8.9 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
8.10 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ million)
Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
8.11 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
8.12 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)

9 Drivers, Challenges, and Opportunity/Restraints
9.1 Market drivers
9.2 Market challenges
9.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
9.4 Market opportunities/restraints

10 Competitive Landscape
10.1 Overview
10.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
10.3 Landscape disruption
Overview on factors of disruption
10.4 Industry risks
Impact of key risks on business

11 Competitive Analysis
11.1 Companies profiled
Companies covered
11.2 Market positioning of companies
Matrix on companies position and classification
11.3 AbbVie Inc.
AbbVie Inc. - Overview
AbbVie Inc. - Product / Service
AbbVie Inc. - Key news
AbbVie Inc. - Key offerings
11.4 AstraZeneca Plc
AstraZeneca Plc - Overview
AstraZeneca Plc - Product / Service
AstraZeneca Plc - Key news
AstraZeneca Plc - Key offerings
11.5 Biogen Inc.
Biogen Inc. - Overview
Biogen Inc. - Product / Service
Biogen Inc. - Key news
Biogen Inc. - Key offerings
11.6 Bristol Myers Squibb Co.
Bristol Myers Squibb Co. - Overview
Bristol Myers Squibb Co. - Product / Service
Bristol Myers Squibb Co. - Key news
Bristol Myers Squibb Co. - Key offerings
11.7 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
11.8 GlaxoSmithKline Plc
GlaxoSmithKline Plc - Overview
GlaxoSmithKline Plc - Business segments
GlaxoSmithKline Plc - Key news
GlaxoSmithKline Plc - Key offerings
GlaxoSmithKline Plc - Segment focus
11.9 Johnson and Johnson Services Inc.
Johnson and Johnson Services Inc. - Overview
Johnson and Johnson Services Inc. - Business segments
Johnson and Johnson Services Inc. - Key news
Johnson and Johnson Services Inc. - Key offerings
Johnson and Johnson Services Inc. - Segment focus
11.10 Merck and Co. Inc.
Merck and Co. Inc. - Overview
Merck and Co. Inc. - Business segments
Merck and Co. Inc. - Key news
Merck and Co. Inc. - Key offerings
Merck and Co. Inc. - Segment focus
11.11 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
11.12 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings

12 Appendix
12.1 Scope of the report
12.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
12.3 Currency conversion rates for US$
Currency conversion rates for US$
12.4 Research methodology
Research methodology
12.5 Data procurement
Information sources
12.6 Data validation
Data validation
12.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
12.8 Data synthesis
Data synthesis
12.9 360 degree market analysis
360 degree market analysis
12.10 List of abbreviations
List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Company Market Positioning
Exhibits9: Parent Market
Exhibits10: Data Table on - Parent Market
Exhibits11: Market characteristics analysis
Exhibits12: Value Chain Analysis
Exhibits13: Offerings of companies included in the market definition
Exhibits14: Market segments
Exhibits15: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits16: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits17: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Historic Market Size - Data Table on Global T-Cell Lymphoma Market 2018 - 2022 ($ million)
Exhibits20: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Type - Market share 2023-2028 (%)
Exhibits31: Data Table on Type - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Peripheral T-cell lymphomas - Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on Peripheral T-cell lymphomas - Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on Peripheral T-cell lymphomas - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Peripheral T-cell lymphomas - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on T-cell lymphoblastic lymphoma - Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on T-cell lymphoblastic lymphoma - Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on T-cell lymphoblastic lymphoma - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on T-cell lymphoblastic lymphoma - Year-over-year growth 2023-2028 (%)
Exhibits42: Market opportunity by Type ($ million)
Exhibits43: Data Table on Market opportunity by Type ($ million)
Exhibits44: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits45: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits46: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits47: Chart on Geographic comparison
Exhibits48: Data Table on Geographic comparison
Exhibits49: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits50: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits51: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits52: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits53: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits54: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits55: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits56: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits57: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits58: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits59: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits60: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits61: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits62: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits63: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits64: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits65: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits66: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits67: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits68: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits69: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits70: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits71: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits72: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits73: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits74: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits75: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits76: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits77: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits78: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits79: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits82: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits83: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits85: Market opportunity By Geographical Landscape ($ million)
Exhibits86: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits87: Impact of drivers and challenges in 2023 and 2028
Exhibits88: Overview on criticality of inputs and factors of differentiation
Exhibits89: Overview on factors of disruption
Exhibits90: Impact of key risks on business
Exhibits91: Companies covered
Exhibits92: Matrix on companies position and classification
Exhibits93: AbbVie Inc. - Overview
Exhibits94: AbbVie Inc. - Product / Service
Exhibits95: AbbVie Inc. - Key news
Exhibits96: AbbVie Inc. - Key offerings
Exhibits97: AstraZeneca Plc - Overview
Exhibits98: AstraZeneca Plc - Product / Service
Exhibits99: AstraZeneca Plc - Key news
Exhibits100: AstraZeneca Plc - Key offerings
Exhibits101: Biogen Inc. - Overview
Exhibits102: Biogen Inc. - Product / Service
Exhibits103: Biogen Inc. - Key news
Exhibits104: Biogen Inc. - Key offerings
Exhibits105: Bristol Myers Squibb Co. - Overview
Exhibits106: Bristol Myers Squibb Co. - Product / Service
Exhibits107: Bristol Myers Squibb Co. - Key news
Exhibits108: Bristol Myers Squibb Co. - Key offerings
Exhibits109: F. Hoffmann La Roche Ltd. - Overview
Exhibits110: F. Hoffmann La Roche Ltd. - Business segments
Exhibits111: F. Hoffmann La Roche Ltd. - Key news
Exhibits112: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits113: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits114: GlaxoSmithKline Plc - Overview
Exhibits115: GlaxoSmithKline Plc - Business segments
Exhibits116: GlaxoSmithKline Plc - Key news
Exhibits117: GlaxoSmithKline Plc - Key offerings
Exhibits118: GlaxoSmithKline Plc - Segment focus
Exhibits119: Johnson and Johnson Services Inc. - Overview
Exhibits120: Johnson and Johnson Services Inc. - Business segments
Exhibits121: Johnson and Johnson Services Inc. - Key news
Exhibits122: Johnson and Johnson Services Inc. - Key offerings
Exhibits123: Johnson and Johnson Services Inc. - Segment focus
Exhibits124: Merck and Co. Inc. - Overview
Exhibits125: Merck and Co. Inc. - Business segments
Exhibits126: Merck and Co. Inc. - Key news
Exhibits127: Merck and Co. Inc. - Key offerings
Exhibits128: Merck and Co. Inc. - Segment focus
Exhibits129: Novartis AG - Overview
Exhibits130: Novartis AG - Business segments
Exhibits131: Novartis AG - Key news
Exhibits132: Novartis AG - Key offerings
Exhibits133: Novartis AG - Segment focus
Exhibits134: Pfizer Inc. - Overview
Exhibits135: Pfizer Inc. - Product / Service
Exhibits136: Pfizer Inc. - Key news
Exhibits137: Pfizer Inc. - Key offerings
Exhibits138: Inclusions checklist
Exhibits139: Exclusions checklist
Exhibits140: Currency conversion rates for US$
Exhibits141: Research methodology
Exhibits142: Information sources
Exhibits143: Data validation
Exhibits144: Validation techniques employed for market sizing
Exhibits145: Data synthesis
Exhibits146: 360 degree market analysis
Exhibits147: List of abbreviations

この商品のレポートナンバー

0000040398

TOP